Deciphering the streamlined genome of Streptomyces xiamenensis 318 as the producer of the anti-fibrotic drug candidate xiamenmycin
Streptomyces xiamenensis 318, a moderate halophile isolated from a mangrove sediment, produces the anti-fibrotic compound xiamenmycin. The whole genome sequence of strain 318 was obtained through long-read single-molecule real-time (SMRT) sequencing, high-throughput Illumina HiSeq and 454 pyrosequen...
Main Authors: | XU, Min-Juan, WANG, Jia-Hua, BU, Xu-Liang, YU, He-Lin, LI, Peng, OU, Hong-Yu, HE, Ying, XU, Fang-Di, HU, Xiao-Yan, Zhu, Xiao-Mei, AO, Ping, Xu, Jun |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705527/ |
Similar Items
-
Characterization of the Xiamenmycin Biosynthesis Gene Cluster in Streptomyces xiamenensis 318
by: Yang, Yong, et al.
Published: (2014) -
Identification and Characterization of an Anti-Fibrotic Benzopyran Compound Isolated from Mangrove-Derived Streptomyces xiamenensis
by: Xu, Min-Juan, et al.
Published: (2012) -
Identification of Two Novel Anti-Fibrotic Benzopyran Compounds Produced by Engineered Strains Derived from Streptomyces xiamenensis M1-94P that Originated from Deep-Sea Sediments
by: You, Zhong-Yuan, et al.
Published: (2013) -
In Vivo Metabolism Study of Xiamenmycin A in Mouse Plasma by UPLC-QTOF-MS and LC-MS/MS
by: Lei, Feng, et al.
Published: (2015) -
Hydrogen Sulfide: A Therapeutic Candidate for Fibrotic Disease?
by: Song, Kai, et al.
Published: (2015)